Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CNTX stock hub

Context Therapeutics Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CNTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

218.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CNTX

In the news

Latest news · CNTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-56.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-37.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CNTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001842952
Company name	Context Therapeutics Inc.
Country	United States
Country code	US
Cusip	21077P108
Employees	15
Employees Change	3%
Employees Change Percent	25
Enterprise value	$164.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-10-20
Isin	US21077P1084
Last refreshed	2026-05-10
Market cap	$218.7M
Market cap category	Micro-Cap
Price	$2.38
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	CNTX
Website	https://www.contexttherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-18.4%
FCF yield	-12.08%
P/B ratio	4.19x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-40.2M
Net Income Growth Years	0%
Profit Per Employee	$-2.7M
ROA	-35.83
Roa5y	-31.87
ROCE	-83.17
ROE	-56.19
Roe5y	-57.66
ROIC	-37.86

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	208.13%
Cagr3y	62.95%
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$58.9M
Cash	$54.5M
Current Assets	$68.4M
Current Liabilities	$8M
Debt	$282,424
Debt Equity	$0.01
Equity	$52.2M
Liabilities	$6.7M
Long Term Assets	$-9.5M
Long Term Liabilities	$-1.4M
Net Cash	$54.2M
Net Cash By Market Cap	$24.81
Net Cash Growth	-30.07%
Net Debt Equity	$-1.04
Tangible Book Value	$52.2M
Tangible Book Value Per Share	$0.57
WACC	12.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.96
Net Working Capital	$-2.4M
Quick ratio	8.34
Working Capital	$52M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-62.94%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	207.89%
200-day SMA	1.62
3Y total return	332.81%
50-day SMA	2.61
50-day SMA vs 200-day SMA	50over200
All Time High	10.87
All Time High Change	-78.1%
All Time High Date	2021-12-01
All Time Low	0.47
All Time Low Change	406.38%
All Time Low Date	2023-05-15
ATR	0.18
Beta	1.57
Beta1y	-0.84
Beta2y	0.48
Ch YTD	61.91
High	2.4
High52	3.62
High52 Date	2026-03-16
High52ch	-34.25%
Low	2.27
Low52	0.49
Low52 Date	2025-05-30
Low52ch	385.71%
Ma50ch	-8.92%
Premarket Change Percent	-1.29
Premarket Price	$2.3
Premarket Volume	473
Price vs 200-day SMA	47.28%
RSI	47.68
RSI Monthly	57.9
RSI Weekly	56.64
Sharpe ratio	1.7x
Sortino ratio	3.1
Total Return	-62.94%
Tr YTD	61.91
Tr1m	-9.16%
Tr1w	4.85%
Tr3m	4.39%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	1
Analyst Price Target Top	$5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.12
Operating Income	$-43.5M
Price target	$6.6
Price Target Change	$177
Price Target Change Top	$110

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	40,531,048%
Float Percent	44.11%
Shares Insiders	1.36%
Shares Institutions	24.46%
Shares Out	91,879,177
Shares Qo Q	-0%
Shares Yo Y	62.94%
Short Float	2.13%
Short Ratio	1.14
Short Shares	0.94

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-27.9M
Average Volume	968,993.15x
Bv Per Share	0.57
CAPEX	$-37,258
Ch1m	-9.16
Ch1w	4.85
Ch1y	207.9
Ch3m	4.39
Ch3y	332.8
Ch6m	112.5
Change	2.15%
Change From Open	2.15
Close	2.33
Days Gap	0
Depreciation Amortization	16,251
Dollar Volume	1,279,678.4
Earnings Date	2026-05-19
Earnings Time	amc
EBIT	$-43.5M
EBITDA	$-43.5M
EPS	$-0.42
F Score	1
FCF	$-26.4M
FCF EV Yield	-16.07x
FCF Per Share	$-0.29
Fiscal Year End	December
Founded	2,015
Investing CF	-2,037,258
Ipr	-52.4
Iprfo	-46.4
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-23
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-23
Ma150	1.87
Ma150ch	27%
Ma20	2.38
Ma20ch	0.21%
Net CF	-34,823,631
Next Earnings Date	2026-05-19
Open	2.33
Optionable	No
Position In Range	84.62
Post Close	2.38
Postmarket Change Percent	0.42
Postmarket Price	$2.39
Ppne	140,066
Pre Close	2.33
Price Date	2026-05-08
Ptbv Ratio	4.19
Relative Volume	0.55x
Share Based Comp	1,446,583
Tr6m	112.5%
Us State	Pennsylvania
Volume	537,680

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CNTX pay a dividend?

Capital-return profile for this ticker.

Performance

CNTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CNTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+24.5%

Float: +44.1% of shares outstanding

Insider ownership

+1.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CNTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.7

Neutral momentum band

Price vs 200-day MA

+47.3%

50/200-day relationship not available

Beta (5Y)

1.57

More volatile than the market

Sharpe ratio

1.70

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CNTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CNTX stock rating?

Context Therapeutics Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CNTX analysis?

The full report lives at /stocks/CNTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CNTX?

The latest report frames CNTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CNTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.